Scrip
Executive Briefing - BRIC by BRIC, building Russian pharma
29 April 2009
Dr Aydar Ishmukhametov, Ekaterina Korduban and Nikola Milevcic
Please Login to read the full article.
29 April 2009
Dr Aydar Ishmukhametov, Ekaterina Korduban and Nikola Milevcic
The Russian pharmaceutical sector has to date suffered from poor liquidity, underdeveloped legislation and a paucity of home-grown talent. The development of the domestic industry is hamstrung by its inherent inability to innovate. Moreover, investors shy away from the types of risky...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Transferring biotech innovations into products remains problematic in eastern Europe
- Russia plans on injecting extra $16 billion in healthcare
- FDA advisory committee recommends approval of miglustat in Niemann-Pick disease
- FDA panel recommends Recordati's carglumic acid for rare disease
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
